Inducible nitric oxide synthase demonstrated in allergic and irritant contact dermatitis

Acta Dermato-Venereologica

Volumn 77, Issue 6, 1997, Pages 436-440

  Ormerod, A D ^a   Dwyer, C M ^a   Reid, A ^a   Copeland, P ^a   Thompson, W D ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Computerised image analysis; Cytokines; Nitric oxide synthase; Sodium lauryl sulphate

Indexed keywords

DODECYL SULFATE SODIUM; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IRRITANT DERMATITIS; MALE; PATCH TEST; PRIORITY JOURNAL; SKIN ALLERGY; SKIN BIOPSY;

ADULT; AGED; BIOPSY, NEEDLE; BLOTTING, WESTERN; CULTURE TECHNIQUES; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, IRRITANT; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; PATCH TESTS; REFERENCE VALUES;

EID: 0030784788     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Vallance P, Collier J. Biology and clinical relevance of nitric oxide. BMJ 1994; 309: 453-457.
2. Moncada S. The L-arginine: nitric oxide pathway. Acta Physiol Scand 1992; 145: 201-227.
3. Änggård E. Nitric oxide: mediator, murderer and medicine. Lancet 1994; 343: 1199-1206.
4. Messmer UK, Ankarcrona M, Nicotera P, et al. p53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994; 355: 23-26.
5. Lundberg JON, Hellstrom PM, Lundberg JM, et al. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994; 344: 1673-1674.
6. Hamid Q, Springall D, R, Riveros-Moreno V, et al. Induction of nitric oxide in asthma. Lancet 1993; 342: 1510-1513.
7. Farrell A, Blake DR, Palmer RMJ, et al. Elevated synovial and serum nitrite suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992; 51: 1219-1222.
8. Leslie TA, Bewley AP, Levell NJ, et al. Involvement of nitric oxide in the erythema of psoriasis. Br J Dermatol 1994; 436: 131.
9. Bewley AP, Goldsmith PC, Levell NJ, et al. The role of nitric oxide (NO) in the erythema of atopic dermatitis. Br J Dermatol 1994; 131: 423.
10. Levell NJ, Leslie TA, Bewley AP, et al. Nitric oxide synthase in dithranol induced erythema. J Invest Dermatol 1994; 103: 435.
11. Quereshi AA, Hosoi J, Xu S, et al. Langerhans cells express inducible nitric oxide synthase and produce nitric oxide. J Invest Dermatol 1996; 107: 815-821.
12. Ormerod AD, Benjamin N, Herriot R, et al. Inducible nitric oxide synthase is upregulated in psoriasis. Clin Exp Dermatol 1995; 20: 277-278.
13. Amin AR, Di Cesare PE, Vyas P, et al. The expression and regulation of nitric oxide synthase in human osteoarthritis affected chondrocytes, evidence for up-regulated neuronal nitric oxide synthase. J Exp Med 1995; 182: 2097-2102.
14. Ikeda M, Ikeda U, Ohkawa F, et al. Nitric oxide synthesis in rat mesangial cells induced by cytokines. Cytokine 1994; 6: 602-607.
15. Larsen CG. Leukocyte activating and chemotactic cytokines in cell-mediated immune reactions of the human skin. (Review). Acta Derm Venereol (Stockh) 1991; Suppl 160: 1-48.
16. Hunziker T, Brand CU, Kapp A, et al. Increased levels of inflammatory cytokines in human skin lymph derived from sodium lauryl sulphate-induced contact dermatitis. Br J Dermatol 1992; 127: 254-257.
17. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 1992; 89: 1398-1402.
18. Enk AH, Katz SI. Early events in the induction phase of contact sensitivity. J Invest Dermatol 1992; 99: 39S-41S.
19. Paludan K, Thestrup-Pedersen K. Quantification of interleukin 8 mRNA in minute epidermal samples by the polymerase chain reaction. J Invest Dermatol 1992; 99: 340-853.
20. Wilmer JL, Burleson FG, Kayama F, et al. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. J Invest Dermatol 1994; 102: 915-922.
21. Kondo S, Pastore S, Shivji GM, et al. Characterization of epidermal cytokine profiles in sensitization and elicitation phases of allergic contact dermatitis as well as irritant contact dermatitis in mouse skin. Lymphokine Cytokine Res 1994; 13: 367-375.
22. Brasch J, Mielke V, Kunne N, et al. Immigration of cells and composition of cell infiltrates in patch test reactions. Contact Dermatitis 1990; 23: 238.
23. Liversidge J, Grabowski P, Ralston SH, et al. Rat retinal pigment epithelial cells express an inducible form of nitric oxide synthase and produce nitric oxide in response to inflammatory cytokines and activated T cells. Immunology 1994; 83: 404-409.
24. Bécherel PA, Mossalayi MD, Le Goff L, et al. IgE-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes: the role of cAMP and nitric oxide. Cell Mol Biol 1994; 40: 283-290.
25. Morita H, Hori M, Kitano Y. Modulation of picryl chloride induced contact hypersensitivity reaction in mice by nitric oxide. J Invest Dermatol 1996; 107: 549-552.
26. Holzer P, Jocic M. Cutaneous vasodilatation induced by nitric oxide-evoked stimulation of afferent nerves in the rat. Br J Pharmacol 1994; 112: 1181-1187.
27. Salvemini D, Manning PT, Zweifel BS, et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the anti-inflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 1995; 96: 301-308.
28. Ianaro A, O'Donnell CA, Di Rosa M, et al. A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology 1994; 82: 370-375.
29. Warren JB, Loi RK, Coughlan ML. Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo. Br J Pharmacol 1993 Jul 1994; 109: 802-806.
30. Deliconstantinos G, Villiotou V, Stravrides JC. Release by ultraviolet B (u.v.B) radiation of nitric oxide (NO) from human keratinocytes: a potential role for nitric oxide in erythema production. Br J Pharmacol 1995; 114: 1257-1265.
31. Rowe A, Farrell AM, Bunker C. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 1997; 136: 18-23.
32. De Caterina R, Libby P, Thannickal VJ, et al. Nitric oxide decreases cytokine induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and pro-inflammatory cytokines. J Clin Invest 1995; 96: 60-68.
33. Shin WS, Hong YH, Peng HB, et al. Nitric oxide attenuates vascular smooth muscle cell activation by interferon gamma. The role of constitutive NF-kappaB activity. J Biol Chem 1996; 271: 11317-11324.
34. Kanwar S, Kubes P. Nitric oxide is an anti-adhesive molecule for leukocytes. New Horiz 1995; 3: 93-104.
35. Gaboury JP, Niu XF, Kubes P. Nitric oxide inhibits numerous features of mast cell induced inflammation. Circulation 1996. 93: 318-326.
36. Moilanen E, Vapaatalo H. Nitric oxide in inflammation and immune responses. Ann Med 1995; 27: 359-365.
37. Liew FY. Regulation of lymphocyte functions by nitric oxide. Curr Opin Immunol 1995; 7: 396-399.
38. Evans CH. Nitric oxide: what role does it play in inflammation and tissue destruction? Agents Actions Suppl 1995; 47: 107-116.